Sartorius Stedim Biotech News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.10.16	Sartorius Stedim Biotech: Information on Document Availability (Businesswire)
25.07.16	First Half of 2016: Sartorius Stedim Biotech Continues Strong Performance (Businesswire)
06.07.16	Sartorius Stedim Biotech acquires U.S. start-up kSep Systems (Businesswire)
04.05.16	Sartorius Stedim Biotech: Share split to become effective May 10, 2016 (Businesswire)
20.04.16	Sartorius Stedim Biotech: Information on Document Availability (Businesswire)
20.04.16	First-Quarter Figures: Sartorius Stedim Biotech off to a Dynamic Start into 2016 (Businesswire)
05.04.16	Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech (Businesswire)
26.02.16	Information on Document Availability (Businesswire)
25.02.16	Sartorius Stedim Biotech: Proposals by the Board of Directors to the Annual General Shareholders’ Meeting (Businesswire)
01.02.16	Preliminary Results for 2015: Sartorius Stedim Biotech with New Highs in Revenues and Earnings (Businesswire)
19.01.16	Sartorius Stedim Biotech: Annual Report of the Liquidity Contract with the Stockbroker Company Gilbert Dupont (Businesswire)
20.10.15	Sartorius Stedim Biotech: Information on Document Availability (Businesswire)
20.10.15	Sartorius Stedim Biotech Continues Strong Growth (Businesswire)
20.10.15	Sartorius Stedim Biotech Continues Strong Growth (Businesswire)
21.07.15	Sartorius Stedim Biotech: Information on Document Availability (Businesswire)
21.07.15	First Half of 2015: Sartorius Stedim Biotech Continues Dynamic Growth (Businesswire)
06.07.15	SARTORIUS STEDIM BIOTECH SA: Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital (Businesswire)
02.07.15	Sartorius Stedim Biotech Acquires Cellca (Businesswire)
20.04.15	Information on Document Availability (Businesswire)
14.04.15	Sartorius Stedim Biotech: Dynamic First Quarter in 2015 \| Forecast Revised Upwards (Businesswire)
07.04.15	Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech (Businesswire)
05.03.15	Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital (Businesswire)
27.02.15	Sartorius Stedim Biotech Group: Notification of Document Availability (Businesswire)
19.02.15	Sartorius Stedim Biotech: Dividend Proposal by the Board of Directors (Businesswire)
04.02.15	SARTORIUS: Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital (Businesswire)
27.01.15	Preliminary Results 2014: Sartorius Stedim Biotech with Strong Growth Across the Entire Product Portfolio and All Regions – Positive Outlook for 2015 (Businesswire)
07.01.15	Sartorius Stedim Biotech: Annual Report of the Liquidity Contract with the Stockbroker Company Gilbert Dupont (Businesswire)
21.10.14	Sartorius Stedim Biotech: Availability of Quarterly Financial Information (Businesswire)
21.10.14	Sartorius Stedim Biotech Continues on the Growth Track (Businesswire)
22.07.14	Announcement of the availability of Sartorius Stedim Biotech Group's Half-Year Report January to June 2014 (Businesswire)
18.07.14	Sartorius Stedim Biotech: Decisions by the Board of Directors on Share Capital Measures (Businesswire)
18.07.14	SARTORIUS STEDIM BIOTECH SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL (Businesswire)
04.07.14	Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital (Businesswire)
06.06.14	Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital (Businesswire)
12.05.14	SARTORIUS STEDIM BIOTECH SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL (Businesswire)
28.04.14	Sartorius Stedim Biotech acquires majority stake in U.S. start-up AllPure Technologies (Businesswire)
28.04.14	Sartorius Stedim Biotech erwirbt Mehrheit an US-Start-up AllPure Technologies (Businesswire)
28.04.14	First-Quarter Figures: Sartorius Stedim Biotech off to a Good Start in 2014 (Businesswire)
04.03.14	Sartorius Stedim Biotech: Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital (Businesswire)
21.02.14	Sartorius Stedim Biotech S.A.: Proposals by the Board of Directors to the AGM (Businesswire)
28.01.14	Preliminary Results 2013: New Highs in Revenues and Earnings – Financial Targets Fully Achieved – Strong 2014 Outlook (Businesswire)
21.10.13	Availability of Quarterly Financial Information (Businesswire)
21.10.13	Sartorius Stedim Biotech on track towards reaching its 2013 targets (Businesswire)
07.10.13	Sartorius Stedim Biotech announces offer to acquire UK company TAP Biosystems Group plc (Businesswire)
03.09.13	Sartorius Stedim Biotech Signs Long-Term Syndicated Loan (Businesswire)
23.07.13	Sartorius Stedim Biotech: Strong growth momentum in the first half of 2013 (Businesswire)
07.01.13	Annual Report of the Liquidity Contract with the Stockbroker Company Gilbert Dupont (Businesswire)
07.01.13	Sartorius Stedim Biotech S.A.: Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital (Businesswire)
19.12.12	Sartorius Stedim Biotech Expands Portfolio by Adding Cell Culture Media (Businesswire)
19.12.12	Sartorius Stedim Biotech erweitert Portfolio um Zellkultur-Medien (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	84.52	5.44 %	K V
Swiss Re	144.45	3.77 %	K V
CieFinRichemont	183.80	2.51 %	K V
Geberit	534.20	2.42 %	K V
Holcim	96.22	2.36 %	K V
Sonova Hldg	292.10	0.00 %	K V
Kuehne+Nagel Int	216.70	-0.05 %	K V
Lonza Grp	576.60	-0.28 %	K V
Nestle	87.60	-1.60 %	K V
Novartis	97.03	-3.66 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Sartorius Stedim Biotech

Aktien Top/Flop

Meistgelesene Nachrichten